Impact of HLA polymorphisms among cadaveric donors on kidney graft allocation

Zorana Grubic1, Marija Burek Kamenaric1, Julijana Kljajic1

  • 1Tissue Typing Centre, Clinical Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.

Insights

This study analyzed human leukocyte antigen (HLA) frequencies in Croatian end-stage renal disease (ESRD) patients, revealing how donor pool diversity impacts kidney transplant matching. A larger, diverse donor pool increases the likelihood of successful, highly matched kidney transplants.

Area of Science:

  • Immunogenetics
  • Transplantation immunology

Background:

  • End-stage renal disease (ESRD) necessitates kidney transplantation.
  • Human Leukocyte Antigen (HLA) matching is crucial for successful transplantation.
  • Understanding HLA frequencies in patient and donor populations optimizes donor pool strategies.

Purpose of the Study:

  • To determine HLA-A, -B, and -DRB1 allele frequencies in Croatian ESRD patients.
  • To compare HLA distribution and mismatches between Croatian and Eurotransplant (ET) donors.
  • To assess the impact of donor pool diversity on kidney transplant outcomes.

Main Methods:

  • Analysis of HLA-A, -B, and -DRB1 frequencies in 861 Croatian ESRD patients.
  • Comparison of HLA mismatches (MMs) in patients receiving grafts from Croatian (n=422) vs. ET (n=285) cadaveric donors.
  • Statistical analysis of HLA gene associations with donor origin and patient sensitization.

Main Results:

  • Specific HLA-B and HLA-DRB1 alleles showed differential distribution between Croatian and ET donors.
  • ABDR MM 000 was more common with ET donors; MM 222 was more frequent with Croatian donors.
  • Sensitized patients were more likely to receive kidneys from ET donors (P < .0001).

Conclusions:

  • Diverse HLA gene distributions across organ donor pools enhance the probability of finding highly matched kidney grafts.
  • Kidney exchange programs benefit from varied HLA profiles to improve transplantation success rates.
  • Strategic donor pool management is key to overcoming HLA matching challenges in ESRD patients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
223
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
203
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
782
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
715
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
82.8K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
235